date:Apr 27, 2012
d a composition patent (US patent #7,943,164 A composition and method for treating diabetes and metabolic disorders, and for achieving weight loss in a subject comprising a combination of naturally occurring compounds) last May.
A second patent was granted in February, 2012 and will be published May 16, said the firm, which says Emulin remains un-oxidized and is stable at high temperatures.
As for regulatory approvals, chlorogenic acid and quercetin are both GRAS, said Ahrens, adding: We are in